论文部分内容阅读
目的:本文主要探讨布地奈德、沙丁胺醇联合给予雾化吸入治疗小儿支气管哮喘(急性发作期)临床疗效。方法:选取我院患有小儿支气管哮喘的患者48例,分为两组进行分别讨论,其中对照组24例患儿给予布地奈德雾化吸入,研究组24例患儿经布地奈德、沙丁胺醇联合雾化吸入,比较两组患儿的治疗效果。结果:研究组临床疗效显著高于对照组,具有统计学意义(P<0.05)。结论:布地奈德、沙丁胺醇联合给予雾化吸入治疗小儿支气管哮喘(急性发作期)可获得更为理想的临床疗效。
Objective: This article mainly discusses the clinical efficacy of budesonide and salbutamol combined with atomized inhalation in the treatment of pediatric bronchial asthma (acute exacerbation). Methods: Forty-eight patients with bronchial asthma in our hospital were selected and divided into two groups for discussion. In the control group, 24 patients received budesonide inhalation. In the study group, 24 patients received budesonide, salbutamol Combined with inhalation, the treatment effect of two groups were compared. Results: The clinical efficacy of the study group was significantly higher than that of the control group, with statistical significance (P <0.05). Conclusion: The combination of budesonide and albuterol in nebulized bronchial asthma (acute exacerbation) can achieve more satisfactory clinical curative effect.